Bionano genomics announces proposed underwritten public offering of common stock

San diego, jan. 19, 2021 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo), announced today that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering. bionano also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of common stock offered in the offering, to cover over-allotments, if any. all of the shares in the proposed offering are to be sold by bionano.
BNGO Ratings Summary
BNGO Quant Ranking